Metformin: A Growing Journey from Glycemic Control to the Treatment of Alzheimer’s Disease and Depression

Role of AMP-Activated Protein Kinase in Mechanism of Metformin Action

Zhou, G., Myers, R., Li, Y., Chen, Y., Shen, X., Fenyk-Melody, J., Wu, M., Ventre, J., Doebber, T., Fujii, N., et al. (2001) · Journal of Clinical Investigation · doi:10.1172/jci13505 · Cited by 5,652 · see citing works

Global, regional, and national burden of neurological disorders, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016

Feigin, V. L., Nichols, E., Alam, T., Bannick, M. S., Beghi, E., Blake, N., Culpepper, W. J., Dorsey, E. R., Elbaz, A., Ellenbogen, R. G., et al. (2019) · The Lancet Neurology · doi:10.1016/s1474-4422(18)30499-x · Cited by 5,644 · see citing works

2016 Alzheimer's disease facts and figures

Alzheimer's Association (2016) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2016.03.001 · Cited by 5,069 · see citing works

AMPK: guardian of metabolism and mitochondrial homeostasis

Herzig, S., & Shaw, R. J. (2017) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm.2017.95 · Cited by 4,094 · see citing works

Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice

Trivedi, M. H., Rush, A. J., Wisniewski, S. R., Nierenberg, A. A., Warden, D., Ritz, L., Norquist, G., Howland, R. H., Lebowitz, B., McGrath, P. J., et al. (2006) · American Journal of Psychiatry · doi:10.1176/appi.ajp.163.1.28 · Cited by 3,879 · see citing works

The mechanisms of action of metformin

Rena, G., Hardie, D. G., & Pearson, E. R. (2017) · Diabetologia · doi:10.1007/s00125-017-4342-z · Cited by 2,287 · see citing works

Stress, Depression, and Neuroplasticity: A Convergence of Mechanisms

Pittenger, C., & Duman, R. S. (2008) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301574 · Cited by 1,795 · see citing works

Brain insulin resistance in type 2 diabetes and Alzheimer disease: concepts and conundrums

Arnold, S. E., Arvanitakis, Z., Macauley-Rambach, S. L., Koenig, A. M., Wang, H.-Y., Ahima, R. S., Craft, S., Gandy, S., Buettner, C., Stoeckel, L. E., et al. (2018) · Nature Reviews Neurology · doi:10.1038/nrneurol.2017.185 · Cited by 1,597 · see citing works

Mitochondrial abnormalities in Alzheimer's disease

Hirai, K., Aliev, G., Nunomura, A., Fujioka, H., Russell, R. L., Atwood, C. S., Johnson, A. B., Kress, Y., Vinters, H. V., Tabaton, M., et al. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-09-03017.2001 · Cited by 1,367 · see citing works

The AMP‐Activated Protein Kinase: Fuel Gauge of the Mammalian Cell?

Hardie, D. G., & Carling, D. (1997) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1997.00259.x · Cited by 1,317 · see citing works

ABAD Directly Links Aß to Mitochondrial Toxicity in Alzheimer's Disease

Lustbader, J. W., Cirilli, M., Lin, C., Xu, H. W., Takuma, K., Wang, N., Caspersen, C., Chen, X., Pollak, S., Chaney, M., et al. (2004) · Science · doi:10.1126/science.1091230 · Cited by 1,303 · see citing works

Alzheimer’s disease is type 3 diabetes—Evidence reviewed

de la Monte, S. M., & Wands, J. R. (2008) · Journal of Diabetes Science and Technology · doi:10.1177/193229680800200619 · Cited by 1,158 · see citing works

Mechanism by which metformin reduces glucose production in type 2 diabetes.

Hundal, R. S., Krssak, M., Dufour, S., Laurent, D., Lebon, V, Chandramouli, V, Inzucchi, S. E., Schumann, W. C., Petersen, K. F., Landau, B. R., et al. (2000) · Diabetes · doi:10.2337/diabetes.49.12.2063 · Cited by 1,052 · see citing works

Review Article: Genetics of Alzheimer Disease

Bekris, L. M., Yu, C.-E., Bird, T. D., & Tsuang, D. W. (2010) · Journal of Geriatric Psychiatry and Neurology · doi:10.1177/0891988710383571 · Cited by 1,029 · see citing works

Cyclophilin D deficiency attenuates mitochondrial and neuronal perturbation and ameliorates learning and memory in Alzheimer's disease

Du, H., Guo, L., Fang, F., Chen, D., Sosunov, A. A., McKhann, G. M., Yan, Y., Wang, C., Zhang, H., Molkentin, J. D., et al. (2008) · Nature Medicine · doi:10.1038/nm.1868 · Cited by 935 · see citing works

Mitochondria and Mitochondrial Cascades in Alzheimer’s disease

Swerdlow, R. H. (2018) · Journal of Alzheimer’s Disease · doi:10.3233/jad-170585 · Cited by 850 · see citing works

Brain metabolism in health, aging, and neurodegeneration

Camandola, S., & Mattson, M. P. (2017) · The EMBO Journal · doi:10.15252/embj.201695810 · Cited by 752 · see citing works

Brain insulin and insulin receptors in aging and sporadic Alzheimer’s disease

Frölich, L., Blum-Degen, D., Bernstein, H.-G., Engelsberger, S., Humrich, J., Laufer, S., Muschner, D., Thalheimer, A., Türk, A., Hoyer, S., et al. (1998) · Journal of Neural Transmission · doi:10.1007/s007020050068 · Cited by 748 · see citing works

The link between depression and diabetes: the search for shared mechanisms

Moulton, C. D., Pickup, J. C., & Ismail, K. (2015) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(15)00134-5 · Cited by 670 · see citing works

The role of neurotrophic factors in adult hippocampal neurogenesis, antidepressant treatments and animal models of depressive-like behavior

Schmidt, H. D., & Duman, R. S. (2007) · Behavioural Pharmacology · doi:10.1097/fbp.0b013e3282ee2aa8 · Cited by 649 · see citing works

Alzheimer’s disease hypothesis and related therapies

Du, X., Wang, X., & Geng, M. (2018) · Translational Neurodegeneration · doi:10.1186/s40035-018-0107-y · Cited by 609 · see citing works

Stimulation of β-Amyloid Precursor Protein Trafficking by Insulin Reduces Intraneuronal β-Amyloid and Requires Mitogen-Activated Protein Kinase Signaling

Gasparini, L., Gouras, G. K., Wang, R., Gross, R. S., Beal, M. F., Greengard, P., & Xu, H. (2001) · Journal of Neuroscience · doi:10.1523/jneurosci.21-08-02561.2001 · Cited by 493 · see citing works

Decreased concentrations of GLUT1 and GLUT3 glucose transporters in the brains of patients with Alzheimer's disease

Simpson, I. A., Chundu, K. R., Davies‐Hill, T., Honer, W. G., & Davies, P. (1994) · Annals of Neurology · doi:10.1002/ana.410350507 · Cited by 490 · see citing works

Insulin Receptor Substrate-2 Deficiency Impairs Brain Growth and Promotes Tau Phosphorylation

Schubert, M., Brazil, D. P., Burks, D. J., Kushner, J. A., Ye, J., Flint, C. L., Farhang-Fallah, J., Dikkes, P., Warot, X. M., Rio, C., et al. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-18-07084.2003 · Cited by 488 · see citing works

Cellular Metabolic Stress: Considering How Cells Respond to Nutrient Excess

Wellen, K. E., & Thompson, C. B. (2010) · Molecular Cell · doi:10.1016/j.molcel.2010.10.004 · Cited by 486 · see citing works

A selective defect of cytochrome c oxidase is present in brain of Alzheimer disease patients

Maurer, I. (2000) · Neurobiology of Aging · doi:10.1016/s0197-4580(00)00112-3 · Cited by 475 · see citing works

Metformin Activates an Atypical PKC-CBP Pathway to Promote Neurogenesis and Enhance Spatial Memory Formation

Wang, J., Gallagher, D., DeVito, L. M., Cancino, G. I., Tsui, D., He, L., Keller, G. M., Frankland, P. W., Kaplan, D. R., & Miller, F. D. (2012) · Cell Stem Cell · doi:10.1016/j.stem.2012.03.016 · Cited by 474 · see citing works

Intracerebral streptozotocin model of type 3 diabetes: Relevance to sporadic Alzheimer’s disease

Lester-Coll, N., Rivera, E. J., Soscia, S. J., Doiron, K., Wands, J. R., & de la Monte, S. M. (2006) · Journal of Alzheimer s Disease · doi:10.3233/jad-2006-9102 · Cited by 467 · see citing works

Brain metabolic dysfunction at the core of Alzheimer's disease

de la Monte, S. M., & Tong, M. (2014) · Biochemical Pharmacology · doi:10.1016/j.bcp.2013.12.012 · Cited by 462 · see citing works

Role of Insulin Secretion and Sensitivity in the Evolution of Type 2 Diabetes in the Diabetes Prevention Program

The Diabetes Prevention Program Research Group (2005) · Diabetes · doi:10.2337/diabetes.54.8.2404 · Cited by 446 · see citing works

Cerebral hypoperfusion and glucose hypometabolism: Key pathophysiological modulators promote neurodegeneration, cognitive impairment, and Alzheimer's disease

Daulatzai, M. A. (2016) · Journal of Neuroscience Research · doi:10.1002/jnr.23777 · Cited by 433 · see citing works

Biguanide metformin acts on tau phosphorylation via mTOR/protein phosphatase 2A (PP2A) signaling

Kickstein, E., Krauß, S., Thornhill, P., Rutschow, D., Zeller, R., Sharkey, J., Williamson, R., Fuchs, M., Köhler, A., Glossmann, H. H., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0912793107 · Cited by 432 · see citing works

Glycogen synthase kinase 3: a drug target for CNS therapies

Bhat, R. V., Haeberlein, S. L. B., & Ávila, J. (2004) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2004.02422.x · Cited by 408 · see citing works

Quantification of metformin by the HPLC method in brain regions, cerebrospinal fluid and plasma of rats treated with lipopolysaccharide

Łabuzek, K., Suchy, D., Gabryel, B., Bielecka, A., Liber, S., & Okopień, B. (2010) · Pharmacological Reports · doi:10.1016/s1734-1140(10)70357-1 · Cited by 405 · see citing works

Increased Risk of Cognitive Impairment in Patients With Diabetes Is Associated With Metformin

Moore, E. M., Mander, A. G., Ames, D. J., Kotowicz, M. A., Carne, R. P., Brodaty, H., Woodward, M., Boundy, K. L., Ellis, K. A., Bush, A. I., et al. (2013) · Diabetes Care · doi:10.2337/dc13-0229 · Cited by 405 · see citing works

Antidiabetic drug metformin (Glucophage ^R ) increases biogenesis of Alzheimer's amyloid peptides via up-regulating <i>BACE1</i> transcription

Chen, Y., Zhou, K., Wang, R., Liu, Y., Kwak, Y.-D., Ma, T., Thompson, R. C., Zhao, Y., Smith, L., Gasparini, L., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0807991106 · Cited by 390 · see citing works

Metformin, Other Antidiabetic Drugs, and Risk of Alzheimer's Disease: A Population‐Based Case–Control Study

Imfeld, P., Bodmer, M., Jick, S. S., & Meier, C. R. (2012) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2012.03916.x · Cited by 389 · see citing works

Incidence of dementia is increased in type 2 diabetes and reduced by the use of sulfonylureas and metformin

Hsu, C.-C., Wahlqvist, M. L., Lee, M.-S., & Tsai, H.-N. (2011) · Journal of Alzheimer s Disease · doi:10.3233/jad-2011-101524 · Cited by 372 · see citing works

Metformin treatment prevents amyloid plaque deposition and memory impairment in APP/PS1 mice

Ou, Z., Kong, X., Sun, X., He, X., Zhang, L., Gong, Z., Huang, J., Xu, B., Long, D., Li, J., et al. (2017) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2017.12.009 · Cited by 370 · see citing works

Effects of the Insulin Sensitizer Metformin in Alzheimer Disease

Koenig, A. M., Mechanic-Hamilton, D. J., Xie, S. X., Combs, M., Cappola, A. R., Xie, L., Detre, J. A., Wolk, D. A., & Arnold, S. E. (2017) · Alzheimer Disease & Associated Disorders · doi:10.1097/wad.0000000000000202 · Cited by 352 · see citing works

Mitochondria and Mood: Mitochondrial Dysfunction as a Key Player in the Manifestation of Depression

Allen, J., Romay-Tallón, R., Brymer, K. J., Caruncho, H. J., & Kalynchuk, L. E. (2018) · Frontiers in Neuroscience · doi:10.3389/fnins.2018.00386 · Cited by 350 · see citing works

Mammalian AMP-activated protein kinase shares structural and functional homology with the catalytic domain of yeast Snf1 protein kinase.

Mitchelhill, K. I., Stapleton, D., Gao, G., House, C. M., Michell, B. J., Katsis, F., Witters, L. A., & Kemp, B. E. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)41951-x · Cited by 338 · see citing works

Metformin Inhibits the Production of Reactive Oxygen Species from NADH:Ubiquinone Oxidoreductase to Limit Induction of Interleukin-1β (IL-1β) and Boosts Interleukin-10 (IL-10) in Lipopolysaccharide (LPS)-activated Macrophages

Kelly, B., Tannahill, G. M., Murphy, M. P., & O'Neill, L. A. J. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.662114 · Cited by 334 · see citing works

Intensive Lifestyle Intervention or Metformin on Inflammation and Coagulation in Participants With Impaired Glucose Tolerance

The Diabetes Prevention Program Research Group (2005) · Diabetes · doi:10.2337/diabetes.54.5.1566 · Cited by 333 · see citing works

Hypoxic activation of AMPK is dependent on mitochondrial ROS but independent of an increase in AMP/ATP ratio

Emerling, B. M., Weinberg, F., Snyder, C., Burgess, Z., Mutlu, G. M., Viollet, B., Budinger, G. R. S., & Chandel, N. S. (2009) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2009.02.019 · Cited by 330 · see citing works

Alzheimer’s disease and insulin resistance: translating basic science into clinical applications

Felice, F. G. D. (2013) · Journal of Clinical Investigation · doi:10.1172/jci64595 · Cited by 328 · see citing works

The insulin receptor tyrosine kinase substrate p58/53 and the insulin receptor are components of CNS synapses

Abbott, M.-A., Wells, D. G., & Fallon, J. R. (1999) · The Journal of Neuroscience · doi:10.1523/jneurosci.19-17-07300.1999 · Cited by 327 · see citing works

Metabolic disturbances connecting obesity and depression

Hryhorczuk, C., Sharma, S., & Fulton, S. E. (2013) · Frontiers in Neuroscience · doi:10.3389/fnins.2013.00177 · Cited by 322 · see citing works

Mitochondrial alterations in Alzheimer's disease

Baloyannis, S. J. (2006) · Journal of Alzheimer s Disease · doi:10.3233/jad-2006-9204 · Cited by 318 · see citing works

Molecular indices of oxidative stress and mitochondrial dysfunction occur early and often progress with severity of Alzheimer's disease

de la Monte, S. M., & Wands, J. R. (2006) · Journal of Alzheimer s Disease · doi:10.3233/jad-2006-9209 · Cited by 318 · see citing works

The Therapeutic Potential of Metformin in Neurodegenerative Diseases

Rotermund, C., Machetanz, G., & Fitzgerald, J. C. (2018) · Frontiers in Endocrinology · doi:10.3389/fendo.2018.00400 · Cited by 310 · see citing works

Role of mitochondria in the mechanism(s) of action of metformin

Vial, G., Detaille, D., & Guigas, B. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00294 · Cited by 303 · see citing works

Peripheral insulin-sensitizer drug metformin ameliorates neuronal insulin resistance and Alzheimer’s-like changes

Gupta, A., Bisht, B., & Dey, C. S. (2011) · Neuropharmacology · doi:10.1016/j.neuropharm.2011.01.033 · Cited by 302 · see citing works

AMPK in the brain: its roles in energy balance and neuroprotection

Ronnett, G. V., Ramamurthy, S., Kleman, A. M., Landree, L. E., & Aja, S. M. (2009) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2009.05916.x · Cited by 300 · see citing works

Abnormal tau, mitochondrial dysfunction, impaired axonal transport of mitochondria, and synaptic deprivation in Alzheimer's disease

Reddy, P. H. (2011) · Brain Research · doi:10.1016/j.brainres.2011.07.052 · Cited by 300 · see citing works

The role of glucose transporters in brain disease: Diabetes and Alzheimer’s disease

Shah, K., DeSilva, S., & Abbruscato, T. (2012) · International Journal of Molecular Sciences · doi:10.3390/ijms131012629 · Cited by 288 · see citing works

Metformin in Amnestic Mild Cognitive Impairment: Results of a Pilot Randomized Placebo Controlled Clinical Trial

Luchsinger, J. A., Perez, T., Chang, H., Mehta, P., Steffener, J., Pradabhan, G., Ichise, M., Manly, J., Devanand, D. P., & Bagiella, E. (2016) · Journal of Alzheimer's Disease · doi:10.3233/jad-150493 · Cited by 285 · see citing works

Should Depressive Syndromes Be Reclassified as “Metabolic Syndrome Type II”?

McIntyre, R. S., Soczynska, J. K., Konarski, J. Z., Woldeyohannes, H. O., Law, C. W. Y., Miranda, A., Fulgosi, D., & Kennedy, S. H. (2007) · Annals of Clinical Psychiatry · doi:10.1080/10401230701653377 · Cited by 277 · see citing works

Early Decline in Glucose Transport and Metabolism Precedes Shift to Ketogenic System in Female Aging and Alzheimer's Mouse Brain: Implication for Bioenergetic Intervention

Ding, F., Yao, J., Rettberg, J. R., Chen, S., & Brinton, R. D. (2013) · PLoS ONE · doi:10.1371/journal.pone.0079977 · Cited by 274 · see citing works

Metformin as an Anticancer Agent

Vancura, A., Bu, P., Bhagwat, M., Zeng, J., & Vancurova, I. (2018) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2018.07.006 · Cited by 274 · see citing works

Reducing insulin resistance with metformin: the evidence today

GIANNARELLI, R., Aragona, M., Coppelli, A., & Prato, S. D. (2003) · Diabetes & Metabolism · doi:10.1016/s1262-3636(03)72785-2 · Cited by 270 · see citing works

The Hippocampus, Neurotrophic Factors and Depression

Masi, G., & Brovedani, P. (2011) · CNS Drugs · doi:10.2165/11595900-000000000-00000 · Cited by 262 · see citing works

Metformin attenuates Alzheimer’s disease-like neuropathology in obese, leptin-resistant mice

Li, J., Deng, J., Sheng, W., & Zuo, Z. (2012) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2012.03.002 · Cited by 260 · see citing works

Clinical and Biochemical Manifestations of Depression: Relation to the Neurobiology of Stress

Gold, P. W., Machado-Vieira, R., & Pavlatou, M. G. (2015) · Neural Plasticity · doi:10.1155/2015/581976 · Cited by 259 · see citing works

Cause and consequence: Mitochondrial dysfunction initiates and propagates neuronal dysfunction, neuronal death and behavioral abnormalities in age-associated neurodegenerative diseases

Gibson, G. E., Starkov, A. A., Blass, J. P., Ratan, R. R., & Beal, M. F. (2009) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2009.08.010 · Cited by 256 · see citing works

AMP-activated Protein Kinase (AMPK) Negatively Regulates Nox4-dependent Activation of p53 and Epithelial Cell Apoptosis in Diabetes

Eid, A. A., Ford, B. M., Block, K. L., Kasinath, B. S., Gorin, Y. C., Ghosh-Choudhury, G., Barnes, J. L., & Abboud, H. E. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.136796 · Cited by 255 · see citing works

Metformin – a Future Therapy for Neurodegenerative Diseases

Markowicz-Piasecka, M., Sikora, J., Szydłowska, A., Skupień, A., Mikiciuk-Olasik, E., & Huttunen, K. (2017) · Pharmaceutical Research · doi:10.1007/s11095-017-2199-y · Cited by 248 · see citing works

Cellular mechanism of metformin action involves glucose transporter translocation from an intracellular pool to the plasma membrane in L6 muscle cells

Hundal, H. S., Ramlal, T., Reyes, R., Leiter, L. A., & Klip, A. (1992) · Endocrinology · doi:10.1210/endo.131.3.1505458 · Cited by 243 · see citing works

NEUROFIBRILLARY PATHOLOGY

Wı́sniewski, H. M., TEKRY, R. D., & HIHANO, A. (1970) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/00005072-197004000-00001 · Cited by 243 · see citing works

Depression: An Important Comorbidity With Metabolic Syndrome in a General Population

Dunbar, J. A., Reddy, P., Davis-Lameloise, N., Philpot, B., Laatikainen, T., Kilkkinen, A., Bunker, S. J., Best, J. D., Vartiainen, E., Kai Lo, S., et al. (2008) · Diabetes Care · doi:10.2337/dc08-0175 · Cited by 241 · see citing works

Cellular Mechanism of Action of Metformin

Klip, A., & Leiter, L. A. (1990) · Diabetes Care · doi:10.2337/diacare.13.6.696 · Cited by 238 · see citing works

Metformin Rapidly Increases Insulin Receptor Activation in Human Liver and Signals Preferentially through Insulin-Receptor Substrate-2

Gunton, J. E., Delhanty, P. J. D., Takahashi, S., & Baxter, R. C. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-021394 · Cited by 231 · see citing works

Insulin Resistance as a Physiological Defense Against Metabolic Stress: Implications for the Management of Subsets of Type 2 Diabetes

Nolan, C. J., Ruderman, N. B., Kahn, S. E., Pedersen, O. B., & Prentki, M. (2015) · Diabetes · doi:10.2337/db14-0694 · Cited by 230 · see citing works

Repurposing Diabetes Drugs for Brain Insulin Resistance in Alzheimer Disease

Yarchoan, M. M., & Arnold, S. E. (2014) · Diabetes · doi:10.2337/db14-0287 · Cited by 228 · see citing works

Acute Antihyperglycemic Mechanisms of Metformin in NIDDM: Evidence for Suppression of Lipid Oxidation and Hepatic Glucose Production

Perriello, G., Misericordia, P., Volpi, E., Santucci, A., Santucci, C., Ferrannini, E., Ventura, M. M., Santeusanio, F., Brunetti, P., & Bolli, G. B. (1994) · Diabetes · doi:10.2337/diab.43.7.920 · Cited by 227 · see citing works

Metformin may produce antidepressant effects through improvement of cognitive function among depressed patients with diabetes mellitus

Guo, M., Mi, J., Jiang, Q., Xu, J., Tang, Y., Tian, G., & Wang, B. (2014) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/1440-1681.12265 · Cited by 225 · see citing works

A Double-Blind Comparison of Sexual Functioning, Antidepressant Efficacy, and Tolerability Between Agomelatine and Venlafaxine XR

Kennedy, S. H., Rizvi, S. J., Fulton, K., & Rasmussen, J. (2008) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e318172b48c · Cited by 211 · see citing works

Functional mitochondria are required for amyloid β‐mediated neurotoxicity

Cardoso, S. M., Santos, S., Swerdlow, R. H., & Oliveira, C. R. (2001) · The FASEB Journal · doi:10.1096/fj.00-0561fje · Cited by 203 · see citing works

Identification of proteomic signatures associated with depression and psychotic depression in post-mortem brains from major depression patients

Martins‐de‐Souza, D., Guest, P. C., Harris, L. W., Vanattou‐Saïfoudine, N., Webster, M. J., Rahmoune, H., & Bahn, S. (2012) · Translational Psychiatry · doi:10.1038/tp.2012.13 · Cited by 202 · see citing works

Cytochrome <i>c</i> oxidase deficiency in neurons decreases both oxidative stress and amyloid formation in a mouse model of Alzheimer's disease

Fukui, H., Diaz, F., Garcia, S., & Moraes, C. T. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0705738104 · Cited by 185 · see citing works

Chronic mild stress damages mitochondrial ultrastructure and function in mouse brain

Gong, Y. L., Chai, Y., Ding, J., Sun, X., & Hu, G. (2010) · Neuroscience Letters · doi:10.1016/j.neulet.2010.11.006 · Cited by 183 · see citing works

Nuclear translocation of AMPK-α1 potentiates striatal neurodegeneration in Huntington’s disease

Ju, T., Chen, H., Lin, J., Chang, C., Chang, W.-C., Kang, J.-J., Sun, C., Tao, M., Tu, P., Chang, C., et al. (2011) · The Journal of Cell Biology · doi:10.1083/jcb.201105010 · Cited by 183 · see citing works

Glucose transport in brain – effect of inflammation

Jurcovicova, J. (2014) · Endocrine Regulations · doi:10.4149/endo_2014_01_35 · Cited by 175 · see citing works

Brain glucose and energy metabolism abnormalities in sporadic Alzheimer disease. Causes and consequences: an update

Hoyer, S. (2000) · Experimental Gerontology · doi:10.1016/s0531-5565(00)00156-x · Cited by 174 · see citing works

Metformin restores insulin secretion altered by chronic exposure to free fatty acids or high glucose: a direct metformin effect on pancreatic beta-cells

Patanè, G., Piro, S., Rabuazzo, A. M., Anello, M., Vigneri, R., & Purrello, F. (2000) · Diabetes · doi:10.2337/diabetes.49.5.735 · Cited by 169 · see citing works

Type 2 Diabetes and Antidiabetic Medications in Relation to Dementia Diagnosis

Cheng, C., Lin, C.-H., Tsai, Y.-W., Tsai, C.-J., Chou, P.-H., & Lan, T.-H. (2014) · The Journals of Gerontology: Series A · doi:10.1093/gerona/glu073 · Cited by 167 · see citing works

Metformin Improves Learning and Memory in the SAMP8 Mouse Model of Alzheimer’s Disease

Farr, S. A., Roesler, E. C., Niehoff, M. L., Roby, D. A., McKee, A. M., & Morley, J. E. (2019) · Journal of Alzheimer s Disease · doi:10.3233/jad-181240 · Cited by 163 · see citing works

A Disturbance in the Neuronal Insulin Receptor Signal Transduction in Sporadic Alzheimer's Disease

Frölich, L., Blum-Degen, D., Riederer, P. F., & Hoyer, S. (1999) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1999.tb07839.x · Cited by 160 · see citing works

Metformin vs sulfonylurea use and risk of dementia in US veterans aged ≥65 years with diabetes

Orkaby, A. R., Cho, K., Cormack, J. B., GAGNON, D. R., & Driver, J. A. (2017) · Neurology · doi:10.1212/wnl.0000000000004586 · Cited by 159 · see citing works

Novel Roles for the Insulin-Regulated Glucose Transporter-4 in Hippocampally Dependent Memory

Pearson-Leary, J., & McNay, E. C. (2016) · Journal of Neuroscience · doi:10.1523/jneurosci.1700-16.2016 · Cited by 158 · see citing works

Metformin ameliorates stress-induced depression-like behaviors via enhancing the expression of BDNF by activating AMPK/CREB-mediated histone acetylation

Fang, W., Zhang, J., Hong, L., Huang, W., Dai, X., Ye, Q., & Chen, X. (2019) · Journal of Affective Disorders · doi:10.1016/j.jad.2019.09.013 · Cited by 154 · see citing works

Metformin promotes anxiolytic and antidepressant-like responses in insulin-resistant mice by decreasing circulating branched-chain amino acids

Zemdegs, J., Martin, H., Pintana, H., Bullich, S., Manta, S., Marqués, M. A., Moro, C., Layé, S., Ducrocq, F., Chattipakorn, N., et al. (2019) · The Journal of Neuroscience · doi:10.1523/jneurosci.2904-18.2019 · Cited by 151 · see citing works

The impact of metformin therapy on hepatic glucose production and skeletal muscle glycogen synthase activity in overweight type II diabetic patients

Johnson, A. B., Webster, J. M., Sum, C. F., Heseltine, L., Argyraki, M., Cooper, B. G., & Taylor, R. (1993) · Metabolism · doi:10.1016/0026-0495(93)90284-u · Cited by 150 · see citing works

Mammalian Target of Rapamycin Regulates Nox4-Mediated Podocyte Depletion in Diabetic Renal Injury

Eid, A. A., Ford, B. M., Bhandari, B. K., Cavaglieri, R. D. C., Block, K. L., Barnes, J. L., Gorin, Y. C., Choudhury, G. G., & Abboud, H. E. (2013) · Diabetes · doi:10.2337/db12-1504 · Cited by 139 · see citing works

Brain insulin resistance: A treatment target for cognitive impairment and anhedonia in depression

Hamer, J., Testani, D. A., Mansur, R. B., Lee, Y. L., Subramaniapillai, M., & McIntyre, R. S. (2019) · Experimental Neurology · doi:10.1016/j.expneurol.2019.01.016 · Cited by 139 · see citing works

Differential effects of metformin on age related comorbidities in older men with type 2 diabetes

Wang, C.-P., Lorenzo, C., Habib, S. L., Jo, B., & Espinoza, S. E. (2017) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2017.01.013 · Cited by 134 · see citing works

Metformin promotes tau aggregation and exacerbates abnormal behavior in a mouse model of tauopathy

Barini, E., Antico, O., Zhao, Y., Asta, F., Tucci, V., Catelani, T., Marotta, R., Xu, H., & Gasparini, L. (2016) · Molecular Neurodegeneration · doi:10.1186/s13024-016-0082-7 · Cited by 126 · see citing works

Metformin activation of AMPK-dependent pathways is neuroprotective in human neural stem cells against Amyloid-beta-induced mitochondrial dysfunction

Chiang, M., Cheng, Y., Chen, S., Yen, C., & Huang, R. (2016) · Experimental Cell Research · doi:10.1016/j.yexcr.2016.08.013 · Cited by 123 · see citing works

Brain metabolic stress and neuroinflammation at the basis of cognitive impairment in Alzheimer’s disease

Felice, F. G. D., & Lourenco, M. V. (2015) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2015.00094 · Cited by 120 · see citing works

AMP-activated protein kinase modulates tau phosphorylation and tau pathology in vivo

Domise, M., Didier, S., Marinangeli, C., Zhao, H., Chandakkar, P., Buée, L., Viollet, B., Davies, P., Marambaud, P., & Vingtdeux, V. (2016) · Scientific Reports · doi:10.1038/srep26758 · Cited by 120 · see citing works

Protective role of metformin against methamphetamine induced anxiety, depression, cognition impairment and neurodegeneration in rat: The role of CREB/BDNF and Akt/GSK3 signaling pathways

Keshavarzi, S., Kermanshahi, S., Karami, L., Motaghinejad, M., Motevalian, M., & Sadr, S. (2019) · NeuroToxicology · doi:10.1016/j.neuro.2019.02.004 · Cited by 120 · see citing works

Association of metformin, sulfonylurea and insulin use with brain structure and function and risk of dementia and Alzheimer’s disease: Pooled analysis from 5 cohorts

Weinstein, G., Davis‐Plourde, K. L., Conner, S. C., Himali, J. J., Beiser, A., Lee, A., Rawlings, A. M., Sedaghat, S., Ding, J., Moshier, E. L., et al. (2019) · PLoS ONE · doi:10.1371/journal.pone.0212293 · Cited by 115 · see citing works

Metformin increases APP expression and processing via oxidative stress, mitochondrial dysfunction and NF-κB activation: Use of insulin to attenuate metformin's effect

Picone, P., Nuzzo, D., Caruana, L., Messina, E., Barera, A., Vasto, S., & Carlo, M. D. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2015.01.017 · Cited by 114 · see citing works

Reduction of Hippocampal Na+, K+-ATPase Activity in Rats Subjected to an Experimental Model of Depression

Gamaro, G. D., STRECK, E. L., Matté, C., Prediger, M. E., Wyse, Â. T. D. S., & Dalmaz, C. (2003) · Neurochemical Research · doi:10.1023/a:1024988113978 · Cited by 113 · see citing works

Effect of metformin treatment on insulin action in diabetic rats: In vivo and in vitro correlations

Rossetti, L., DeFronzo, R. A., Gherzi, R., Stein, P., Andraghetti, G., Falzetti, G., Shulman, G. I., Klein-Robbenhaar, E., & Cordera, R. (1990) · Metabolism · doi:10.1016/0026-0495(90)90259-f · Cited by 111 · see citing works

Increased Glucose Transport into Neurons Rescues Aβ Toxicity in Drosophila

Niccoli, T., Cabecinha, M., Tillmann, A., Kerr, F., Wong, C. T., Cardenes, D., Vincent, A. J., Bettedi, L., Li, L., Grönke, S., et al. (2016) · Current Biology · doi:10.1016/j.cub.2016.07.017 · Cited by 111 · see citing works

Metformin Treatment Alters Memory Function in a Mouse Model of Alzheimer's Disease

DiTacchio, K. A., Heinemann, S. F., & Dziewczapolski, G. (2015) · Journal of Alzheimer s Disease · doi:10.3233/jad-141332 · Cited by 110 · see citing works

Structure, chromosomal localization, and brain expression of human Cx36 gene

Belluardo, N., Salinaro, A. T., Mudò, G., Hurd, Y. L., & Condorelli, D. F. (1999) · Journal of Neuroscience Research · doi:10.1002/(sici)1097-4547(19990901)57:5 · Cited by 110 · see citing works

Metformin Protects the Brain Against the Oxidative Imbalance Promoted by Type 2 Diabetes

Correia, S. C., Carvalho, C., Santos, M. S., Proenca, T., Nunes, E., Duarte, A. I., Monteiro, P. F., Seiça, R. M. F., Oliveira, C. R., & Moreira, P. I. (2008) · Medicinal Chemistry · doi:10.2174/157340608784872299 · Cited by 110 · see citing works

Mitochondria, Microglia, and the Immune System—How Are They Linked in Affective Disorders?

Culmsee, C., Michels, S., Scheu, S., Arolt, V., Dannlowski, U., & Alferink, J. (2019) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2018.00739 · Cited by 110 · see citing works

Functional Alterations in Alzheimerʼs Disease

Harr, S. D., Simonian, N. A., & Hyman, B. T. (1995) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/00005072-199501000-00005 · Cited by 108 · see citing works

Insulin resistance in the Zucker diabetic fatty rat: a metabolic characterisation of obese and lean phenotypes

Leonard, B. L., Watson, R. N., Loomes, K. M., Phillips, A. R. J., & Cooper, G. J. S. (2005) · Acta Diabetologica · doi:10.1007/s00592-005-0197-8 · Cited by 102 · see citing works

Damaged neuronal energy metabolism and behavior are improved by Ginkgo biloba extract (EGb 761)

Hoyer, S., Lannert, H., Nöldner, M., & Chatterjee, S. S. (1999) · Journal of Neural Transmission · doi:10.1007/s007020050232 · Cited by 102 · see citing works

Differential metformin dose-dependent effects on cognition in rats: role of Akt

Mostafa, D. K., Ismail, C. A., & Ghareeb, D. A. (2016) · Psychopharmacology · doi:10.1007/s00213-016-4301-2 · Cited by 101 · see citing works

Adenosine monophosphate-activated protein kinase overactivation leads to accumulation of α-synuclein oligomers and decrease of neurites

Jiang, P., Gan, M., Ebrahim, A. S., Castanedes‐Casey, M., Dickson, D. W., & Yen, S.-H. C. (2012) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2012.11.001 · Cited by 99 · see citing works

Metformin and the Risk of Dementia in Type 2 Diabetes Patients

Chin-Hsiao, T. (2018) · Aging and Disease · doi:10.14336/ad.2017.1202 · Cited by 98 · see citing works

Rat models of dementia based on reductions in regional glucose metabolism, cerebral blood flow and cytochrome oxidase activity

Weinstock, M., & Shoham, S. (2004) · Journal of Neural Transmission · doi:10.1007/s00702-003-0058-y · Cited by 95 · see citing works

Identifying Metabolic Risks With Antipsychotics and Monitoring and Management Strategies

Newcomer, J. W., & Sernyak, M. J. (2007) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.0707e17 · Cited by 93 · see citing works

The Anti-Diabetic Drug Metformin Reduces BACE1 Protein Level by Interfering with the MID1 Complex

Hettich, M. M., Matthes, F., Ryan, D. P., Griesche, N., Schröder, S., Dorn, S., Krauß, S., & Ehninger, D. (2014) · PLoS ONE · doi:10.1371/journal.pone.0102420 · Cited by 90 · see citing works

Brain glucose metabolism in an animal model of depression

Detka, J., Kurek, A., Kucharczyk, M. W., Głombik, K., Basta‐Kaim, A., Kubera, M., Lasoń, W., & Budziszewska, B. (2015) · Neuroscience · doi:10.1016/j.neuroscience.2015.03.046 · Cited by 82 · see citing works

Nutrient excess and altered mitochondrial proteome and function contribute to neurodegeneration in diabetes

Chowdhury, S. K. R., Dobrowsky, R. T., & Fernyhough, P. (2011) · Mitochondrion · doi:10.1016/j.mito.2011.06.007 · Cited by 82 · see citing works

Insulin sensitivity, proinflammatory markers and adiponectin in young males with different subtypes of depressive disorder

Hung, Y., Hsieh, C., Chen, Y., Pei, D., Kuo, S., Shen, D., Sheu, W. H., & Chen, Y. (2007) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2007.02963.x · Cited by 79 · see citing works

Repositioning of diabetes treatments for depressive symptoms: A systematic review and meta-analysis of clinical trials

Moulton, C. D., Hopkins, C. W. P., Ismail, K., & Stahl, D. R. (2018) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2018.05.010 · Cited by 79 · see citing works

Metformin and ascorbic acid combination therapy ameliorates type 2 diabetes mellitus and comorbid depression in rats

Shivavedi, N., Kumar, M., Tej, G. N. V. C., & Nayak, P. K. (2017) · Brain Research · doi:10.1016/j.brainres.2017.08.019 · Cited by 72 · see citing works

Metabolic stress is a primary pathogenic event in transgenic Caenorhabditis elegans expressing pan-neuronal human amyloid beta

Teo, E., Ravi, S., Barardo, D., Kim, H.-S., Fong, S., Cazenave-Gassiot, A., Tan, T. Y., Ching, J., Kovalik, J.-P., Wenk, M. R., et al. (2019) · eLife · doi:10.7554/elife.50069 · Cited by 72 · see citing works

Metabolic Stress and Cardiovascular Disease in Diabetes Mellitus

Chen, Y., Zhao, X., & Wu, H. (2019) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.119.312192 · Cited by 71 · see citing works

Metabolic adverse effects of olanzapine on cognitive dysfunction: A possible relationship between BDNF and TNF-alpha

Zhang, C., Fang, X., Yao, P., Mao, Y., Cai, J., Zhang, Y., Chen, M., Fan, W., Tang, W., & Song, L. (2017) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2017.04.014 · Cited by 67 · see citing works

GLP-1 receptor agonist liraglutide reverses long-term atypical antipsychotic treatment associated behavioral depression and metabolic abnormalities in rats

Sharma, A. N., Ligade, S. S., Sharma, J. N., Shukla, P., Elased, K. M., & Lucot, J. B. (2014) · Metabolic Brain Disease · doi:10.1007/s11011-014-9591-7 · Cited by 66 · see citing works

Potential role of insulin on the pathogenesis of depression

Zou, X.-H., Sun, L.-H., Yang, W., Li, B.-J., & Cui, R.-J. (2020) · Cell Proliferation · doi:10.1111/cpr.12806 · Cited by 66 · see citing works

The effects of perturbed energy metabolism on the processing of amyloid precursor protein in PC12 cells

Webster, M.-T., Pearce, B. R., Bowen, D. M., & Francis, P. T. (1998) · Journal of Neural Transmission · doi:10.1007/s007020050098 · Cited by 62 · see citing works

Par-4: An Emerging Pivotal Player in Neuronal Apoptosis and Neurodegenerative Disorders

Mattson, M. P., Duan, W., Chan, S. L., & Camandola, S. (1999) · Journal of Molecular Neuroscience · doi:10.1385/jmn:13:1-2:17 · Cited by 61 · see citing works

AMPK in Neurodegenerative Diseases

Domise, M., & Vingtdeux, V. (2016) · Proceedings of the Fourth International Symposium on Polarization Phenomena in Nuclear Reactions · doi:10.1007/978-3-319-43589-3_7 · Cited by 59 · see citing works

The Full Spectrum of Alzheimer’s Disease Is Rooted in Metabolic Derangements That Drive Type 3 Diabetes

de la Monte, S. M. (2019) · Advances in experimental medicine and biology · doi:10.1007/978-981-13-3540-2_4 · Cited by 59 · see citing works

NUCLEOSIDE PHOSPHATASE ACTIVITIES ASSOCIATED WITH THE TANGLES AND PLAQUES OF ALZHEIMERʼS DISEASE

Johnson, T., & Blum, N. R. (1970) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/00005072-197007000-00009 · Cited by 58 · see citing works

Régulation du métabolisme énergétique par l’AMPK

Foretz, M., Taleux, N., Guigas, B., Horman, S., Beauloye, C., Andréelli, F., Bertrand, L., & Viollet, B. (2006) · médecine/sciences · doi:10.1051/medsci/2006224381 · Cited by 57 · see citing works

Risk factors for depression in elderly diabetic patients and the effect of metformin on the condition

Chen, F., Wei, G., Wang, Y., Liu, T., Huang, T., Wei, Q., Ma, G., & Wang, D. (2019) · BMC Public Health · doi:10.1186/s12889-019-7392-y · Cited by 56 · see citing works

Evaluation of Krebs cycle enzymes in the brain of rats after chronic administration of antidepressants

Scaini, G., Santos, P. M. L., Benedet, J., Rochi, N., Gomes, L. M., Borges, L. S., Rezin, G. T., Pezente, D. P., Quevedo, J., & STRECK, E. L. (2010) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2010.03.006 · Cited by 53 · see citing works

Effects of additional exercise training on epicardial, intra-abdominal and subcutaneous adipose tissue in major depressive disorder: A randomized pilot study

Kahl, K. G., Kerling, A., Tegtbur, U., Guetzlaff, E., Herrmann, J., BORCHERT, L. R. D., Ateş, Z., Westhoff‐Bleck, M., Hueper, K., & Hartung, D. (2015) · Journal of Affective Disorders · doi:10.1016/j.jad.2015.12.015 · Cited by 52 · see citing works

Combined Fluoxetine and Metformin Treatment Potentiates Antidepressant Efficacy Increasing IGF2 Expression in the Dorsal Hippocampus

Poggini, S., Golia, M. T., Alboni, S., Milior, G., Sciarria, L. P., Viglione, A., Bon, G. M., Brunello, N., Puglisi‐Allegra, S., Limatola, C., et al. (2019) · Neural Plasticity · doi:10.1155/2019/4651031 · Cited by 50 · see citing works

A pilot trial of metformin for insulin resistance and mood disturbances in adolescent and adult women with polycystic ovary syndrome

Erensoy, H., Niafar, M., Rad, S. G., Aghamohammadzadeh, N., & Nader, N. D. (2018) · Gynecological Endocrinology · doi:10.1080/09513590.2018.1498476 · Cited by 47 · see citing works

Association between diabetes and mood disorders and the potential use of anti-hyperglycemic agents as antidepressants

Grigolon, R. B., Brietzke, E. M., Mansur, R. B., Idzikowski, M. A., Gerchman, F., Felice, F. G. D., & McIntyre, R. S. (2019) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2019.109720 · Cited by 46 · see citing works

Impact of some oral hypoglycemic agents on type 2 diabetes-associated depression and reserpine-induced depression in rats: the role of brain oxidative stress and inflammation

Soliman, E., Essmat, N., Mahmoud, M. F., & Mahmoud, A. A. A. (2020) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-020-01838-w · Cited by 45 · see citing works

Antidiabetic Drug Metformin Ameliorates Depressive-Like Behavior in Mice with Chronic Restraint Stress via Activation of AMP-Activated Protein Kinase

Ai, H., Fang, W., Hanyi, H., Xupang, H., & Lu, W. (2020) · Aging and Disease · doi:10.14336/ad.2019.0403 · Cited by 44 · see citing works

Future prospects in depression research

Holtzheimer, P. E., & Nemeroff, C. B. (2006) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2006.8.2/pholtzheimer · Cited by 41 · see citing works

Metformin Alleviated Aβ-Induced Apoptosis via the Suppression of JNK MAPK Signaling Pathway in Cultured Hippocampal Neurons

Chen, B., Teng, Y., Zhang, X., Lv, X., & Yin, Y. (2016) · BioMed Research International · doi:10.1155/2016/1421430 · Cited by 39 · see citing works

Possible role of GLP-1 in antidepressant effects of metformin and exercise in CUMS mice

Liu, W., Liu, J., Huang, Z., Cui, Z., Liu, W., Liu, W., & Qi, Z. (2018) · Journal of Affective Disorders · doi:10.1016/j.jad.2018.12.112 · Cited by 36 · see citing works

Colorectal and Prostate Cancer Risk in Diabetes: Metformin, an Actor Behind the Scene

Anwar, M. A., Kheir, W. A., Eid, S., Fares, J., Liu, X., Eid, A. H., & Eid, A. A. (2014) · Journal of Cancer · doi:10.7150/jca.9726 · Cited by 35 · see citing works

Brain Metabolic Alterations in Rats Showing Depression-Like and Obesity Phenotypes

Głombik, K., Detka, J., Góralska, J., Kurek, A., Solnica, B., & Budziszewska, B. (2019) · Neurotoxicity Research · doi:10.1007/s12640-019-00131-w · Cited by 35 · see citing works

AMPK Mediates Glucocorticoids Stress-Induced Downregulation of the Glucocorticoid Receptor in Cultured Rat Prefrontal Cortical Astrocytes

Yuan, S., Liu, J., Zhou, J., Lü, W., Zhou, H.-Y., Long, L., Hu, Z., Ni, L., Wang, Y., Chen, J., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0159513 · Cited by 34 · see citing works

Effects of metformin on lipopolysaccharide-induced depressive-like behavior in mice and its mechanisms

Yang, S., Chen, X., Xu, Y., Hao, Y., & Meng, X. (2020) · Neuroreport · doi:10.1097/wnr.0000000000001401 · Cited by 34 · see citing works

Amyloid-β and Glucose Metabolism in Alzheimer's Disease

Furst, A. J., & Lal, R. (2011) · Journal of Alzheimer s Disease · doi:10.3233/jad-2011-0066 · Cited by 31 · see citing works

Potential involvement of the mitochondrial unfolded protein response in depressive-like symptoms in mice

Kambe, Y., & Miyata, A. (2015) · Neuroscience Letters · doi:10.1016/j.neulet.2015.01.006 · Cited by 30 · see citing works

Metformin and fatty acids.

Muntoni, S. (1999) · Diabetes Care · doi:10.2337/diacare.22.1.179 · Cited by 27 · see citing works

Unmasking the interplay between mTOR and Nox4: novel insights into the mechanism connecting diabetes and cancer

Mroueh, F. M., Noureldein, M. H., Zeidan, Y. H., Boutary, S. S., Irani, S. A. M., Eid, S., Haddad, M. E., Barakat, R., Harb, F., Costantine, J., et al. (2019) · The FASEB Journal · doi:10.1096/fj.201900396rr · Cited by 26 · see citing works

Spinocerebellar Ataxia Type 1: Molecular Mechanisms of Neurodegeneration and Preclinical Studies.

Ortiz, J. M. P., & Orr, H. (2018) · Advances in Experimental Medicine and Biology · doi:10.1007/978-3-319-71779-1_6 · Cited by 23 · see citing works

Metformin/rosiglitazone combination pill (Avandamet®) for the treatment of patients with Type 2 diabetes

Smiley, D. D., & Umpierrez, G. E. (2007) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.8.9.1353 · Cited by 15 · see citing works

Changes in [18F]Fluoro-2-deoxy-d-glucose incorporation induced by doxorubicin and anti-HER antibodies by breast cancer cells modulated by co-treatment with metformin and its effects on intracellular signalling

Cooper, A. C., Fleming, I. N., Phyu, S. M., & Smith, T. (2015) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-015-1909-2 · Cited by 14 · see citing works

Insulin resistance is associated with smaller brain volumes in a preliminary study of depressed and obese children

Phillips, O. R., Onopa, A., Zaiko, Y. V., & Singh, M. K. (2018) · Pediatric Diabetes · doi:10.1111/pedi.12672 · Cited by 14 · see citing works

A novel therapeutic approach to colorectal cancer in diabetes: role of metformin and rapamycin

Geagea, A. G., Rizzo, M., Jurjus, A. R., Cappello, F., Leone, A., Tomasello, G., Gracia, C., Kattar, S. A., Massaad-Massade, L., & Eid, A. A. (2019) · Oncotarget · doi:10.18632/oncotarget.26641 · Cited by 12 · see citing works

Islet Compensation in Metabolic Stress: Lessons from Animal Models

Singh, H. (2016) · Current Diabetes Reviews · doi:10.2174/1573399811666150617161915 · Cited by 6 · see citing works

Major depressive disorder

Marx, W., Penninx, B. W. J. H., Solmi, M., Furukawa, T. A., Firth, J., Carvalho, A. F., & Berk, M. (2023) · Nature Reviews Disease Primers · doi:10.1038/s41572-023-00454-1 · Cited by 850 · see citing works

Comorbidity between major depressive disorder and physical diseases: a comprehensive review of epidemiology, mechanisms and management

Berk, M., Köhler‐Forsberg, O., Turner, M., Penninx, B. W. J. H., Wrobel, A., Firth, J., Loughman, A., Reavley, N. J., McGrath, J. J., Momen, N. C., et al. (2023) · World Psychiatry · doi:10.1002/wps.21110 · Cited by 336 · see citing works

Metformin: Is it a drug for all reasons and diseases?

Triggle, C. R., Mohammed, I., Bshesh, K., Marei, I., Ye, K., Ding, H., MacDonald, R. S., Hollenberg, M. D., & Hill, M. A. (2022) · Metabolism · doi:10.1016/j.metabol.2022.155223 · Cited by 282 · see citing works

Type 2 diabetes mellitus-associated cognitive dysfunction: Advances in potential mechanisms and therapies

Luo, A., Xie, Z., Wang, Y., Wang, X., Li, S., Yan, J., Zhan, G., Zhou, Z., Zhao, Y., & Li, S. (2022) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2022.104642 · Cited by 166 · see citing works

Deciphering the Roles of Metformin in Alzheimer’s Disease: A Snapshot

Liao, W., Xu, J., Li, B., Ruan, Y., Li, T., & Liu, J. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.728315 · Cited by 84 · see citing works

Mechanistic insight into the role of metformin in Alzheimer's disease

Sanati, M., Aminyavari, S., Afshari, A. R., & Sahebkar, A. (2022) · Life Sciences · doi:10.1016/j.lfs.2021.120299 · Cited by 43 · see citing works

Metformin a Potential Pharmacological Strategy in Late Onset Alzheimer’s Disease Treatment

Poor, S. R., Ettcheto, M., Cano, A. C., Sánchez‐López, E., Manzine, P. R., Olloquequi, J., Camins, A., & Javan, M. (2021) · Pharmaceuticals · doi:10.3390/ph14090890 · Cited by 40 · see citing works

Insulin resistance: The role in comorbid type 2 diabetes mellitus and depression

Yao, J., Zhu, C., Sun, Y., Huang, Y., Li, Q., Liao, H.-M., Deng, X.-J., & Li, W.-M. (2025) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2025.106218 · Cited by 41 · see citing works

Metformin attenuates sepsis-induced neuronal injury and cognitive impairment

Qin, Z., Zhou, C., Xiao, X., & Guo, C. (2021) · BMC Neuroscience · doi:10.1186/s12868-021-00683-8 · Cited by 30 · see citing works

Emerging role of Metformin in Alzheimer’s disease: A translational view

Ríos, J. A., Bórquez, J. C., Godoy, J. A., Zolezzi, J. M., Furrianca, M. C., & Inestrosa, N. C. (2024) · Ageing Research Reviews · doi:10.1016/j.arr.2024.102439 · Cited by 20 · see citing works

Environmental enrichment and the combined interventions of EE and metformin enhance hippocampal neuron survival and hippocampal-dependent memory in type 2 diabetic rats under stress through the BDNF-TrkB signaling pathways

Ismail, T. R., Yap, C. G., Naidu, R., Shri, L., & Pamidi, N. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.116729 · Cited by 18 · see citing works

Effect of Metformin on Plasma and Cerebrospinal Fluid Biomarkers in Non-Diabetic Older Adults with Mild Cognitive Impairment Related to Alzheimer’s Disease

Weinberg, M. S., He, Y., Kivisäkk, P., Arnold, S. E., & Das, S. (2023) · Journal of Alzheimer s Disease · doi:10.3233/jad-230899 · Cited by 17 · see citing works

Metformin regulates multiple signaling pathways within castration-resistant human prostate cancer cells

Olokpa, E., Mandape, S. N., Pratap, S., & Stewart, L. V. (2022) · BMC Cancer · doi:10.1186/s12885-022-10115-3 · Cited by 12 · see citing works

Metformin: A New Inhibitor of the Wnt Signaling Pathway in Cancer

Conza, D., Mirra, P., Fiory, F., Insabato, L., Nicolò, A., Bèguinot, F., & Ulianich, L. (2023) · Cells · doi:10.3390/cells12172182 · Cited by 12 · see citing works

The Risk of Age-Related Macular Degeneration Is Reduced in Type 2 Diabetes Patients Who Use Metformin

Tseng, C. (2023) · Pharmaceuticals · doi:10.3390/ph16020224 · Cited by 11 · see citing works

Possible role of metformin as an antidepressant in diabetes

Pedreáñez, A. B., Carrero, Y. N., Vargas, R., Hernández-Fonseca, J. P., & Mosquera-Sulbarán, J. (2024) · Journal of Affective Disorders · doi:10.1016/j.jad.2024.01.228 · Cited by 8 · see citing works

The ameliorative potential of metformin against aluminum‐induced neurotoxicity: Insights from in vitro studies

Sanajou, S., Yirün, A., Demirel, G., Erkekoğlu, P., Şahin, G., & Baydar, T. (2024) · Journal of Applied Toxicology · doi:10.1002/jat.4695 · Cited by 7 · see citing works

Risk of antidepressant initiation among users of cardiovascular agents and metformin.

Bojanić, I., Bjerkeset, O. A., Williams, L. J., Berk, M., Bjø‌rngaard, J. H., Sund, E. R., & Sletvold, H. (2023) · Pharmacology Research & Perspectives · doi:10.1002/prp2.1078 · Cited by 2 · see citing works

Metformin relieves bone cancer pain by reducing TGFβRI-TRPV1 signaling in rats

Zhou, F. J., Qian, H., Wang, K., Gu, Y.-J., Liu, P.-L., Zhang, L., Chen, L., Yu, S., Chen, Y., & Zhang, H. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e34991 · Cited by 2 · see citing works

Severe depressive symptoms in patients with hypertension: Are antihypertensive medications implicated?

Gammoh, O., Alqudah, A. M., shaikh, H. A., & Al-Shudifat, A.-E. (2023) · The International Journal of Psychiatry in Medicine · doi:10.1177/00912174231173339 · Cited by 2 · see citing works

Effect and safety of combined Gegen Qinlian decoction/metformin in the treatment of diabetes mellitus in patients, and its influence on serum C peptide and glycosylated hemoglobin

Chen, J., Xu, Y., Zhao, Y., Liu, G., Cui, J., Li, Y., & Li, W. (2022) · Tropical Journal of Pharmaceutical Research · doi:10.4314/tjpr.v21i5.20 · Cited by 2 · see citing works

A Growing Journey From Neurotrophins To Metabotrophins In Cardiometabolic Diseases

Aloe, L., Vinciguerra, M., Tonchev, A. B., Fiore, M., Deleva, N. S., Fröhlich, J., & Chaldakov, G. N. (2021) · Adipobiology · doi:10.14748/adipo.v11.8558 · Cited by 1 · see citing works

Drug Repurposing in Neurodegenerative and Cardiovascular Diseases

Eid, A. H. (2021) · Current Medicinal Chemistry · doi:10.2174/092986732812210419080559 · Cited by 1 · see citing works

Dulaglutide ameliorates chronic stress-induced cognitive impairment via regulating gut microbiota and serum metabolites in micePreprint

Zhang, S., Jin, M., Huang, B., Hou, Z., Fei, D., Zhang, X., Gao, C., Lv, P., Shi, H., & Wang, T. (2024) · Research Square · doi:10.21203/rs.3.rs-5279490/v1 · Cited by 1 · see citing works

Additional file 1 of Metformin regulates multiple signaling pathways within castration-resistant human prostate cancer cells

Olokpa, E., Mandape, S. N., Pratap, S., & Stewart, L. M. V. (2022) · Figshare · doi:10.6084/m9.figshare.21251623

Additional file 1 of Metformin attenuates sepsis-induced neuronal injury and cognitive impairment

Qin, Z., Zhou, C., Xiao, X., & Guo, C. (2021) · Figshare · doi:10.6084/m9.figshare.17210662

Diabetes-Induced depression: A molecular perspective

Hedayati‐Moghadam, M., Razazpour, F., Mirzaee, F., Hakemi, Z., Dalfardi, M., & Baghcheghi, Y. (2025) · Journal of Diabetes & Metabolic Disorders · doi:10.1007/s40200-025-01806-2

Metformin as a potential neuroprotective agent: Molecular mechanisms, clinical evidence and therapeutic repurposing in neurodegenerative disorders

Hazarika, S., Sayoo, E., Barman, N., Tanti, M., Bordoloi, T., Saikia, D., Gogoi, H., Laskar, R. F., & Debnath, R. (2026) · iPharma · doi:10.1016/j.iphar.2026.100004

Metformin in Neurodegenerative Diseases: Mechanisms and Therapeutic Implications

Langmead, A. P., Keane, B., Jacob, J. A., & Ramana, K. V. (2026) · Current Neuropharmacology · doi:10.2174/011570159x476604260704180015

Metformin – a Future Therapy for Neurodegenerative Diseases

Markowicz-Piasecka, M., Sikora, J., Szydłowska, A., Skupień, A., Mikiciuk-Olasik, E., & Huttunen, K. (2017) · Pharmaceutical Research · doi:10.1007/s11095-017-2199-y · Cited by 248 · see citing works

Overview of Metformin and Neurodegeneration: A Comprehensive Review

Kruczkowska, W., Gałęziewska, J., Buczek, P., Płuciennik, E., Kciuk, M., & Śliwińska, A. (2025) · Pharmaceuticals · doi:10.3390/ph18040486 · Cited by 50 · see citing works

Mechanistic Insights into metformin’s neuroprotective effects against drug-induced neurotoxicity

Tyagi, S., Hussain, M., Tyagi, A., Sharma, R. V., Shekhar, N., & Ilma, B. (2026) · Metabolic Brain Disease · doi:10.1007/s11011-026-01898-6